SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
85 hedge funds and large institutions have $141M invested in scPharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less capital invested
Capital invested by funds: $170M → $141M (-$29M)
35% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 26
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
85
Holding in Top 10
1
Calls
$614K
Puts
$78K
Top Buyers
| 1 | +$5.58M | |
| 2 | +$3.6M | |
| 3 | +$2.24M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$1.77M |
| 5 |
BlackRock
New York
|
+$1.52M |
Top Sellers
| 1 | -$3.49M | |
| 2 | -$2.4M | |
| 3 | -$2.36M | |
| 4 |
Walleye Capital
New York
|
-$2.17M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.46M |